MedPath

Building a Community-based Network to Promote Smoking Cessation

Not Applicable
Completed
Conditions
Smoking
Registration Number
NCT02968199
Lead Sponsor
The University of Hong Kong
Brief Summary

This study describes the development of a community-based network to promote smoking cessation among female smokers in Hong Kong.

Detailed Description

There is growing concern about the use of tobacco among women in Hong Kong. Nevertheless, nearly all of them reported that they had not attended smoking cessation services provided by the government and other organizations, of which only 6.7% indicated that they would like to attend, demonstrating the need for population-based smoking cessation interventions targeting female smokers in Hong Kong. In response to the increased number of female smokers and their low usage rates of smoking cessation services, the first smoking cessation hotline for female smokers in Hong Kong was established in 2006 by the University of Hong Kong. The aim of this study was to describe the development of a community-based network to promote the smoking cessation hotline among female smokers in Hong Kong.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
457
Inclusion Criteria
  • Female Hong Kong Chinese current smokers
  • Aged 15 years or above
  • Able to speak and understand Cantonese
  • Willing to receive face-to-face or telephone counseling
Exclusion Criteria
  • Those who were participating in other smoking cessation programs or services

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
self-reported 7-day point prevalence of abstinence6 months
Secondary Outcome Measures
NameTimeMethod
Levels of self-efficacy at six monthssix months
self-reported reduction of ≥ 50% in cigarette consumption6 months
Levels of self-efficacy at baselinebaseline

Trial Locations

Locations (1)

The University of Hong Kong

🇨🇳

Hong Kong SAR, China

The University of Hong Kong
🇨🇳Hong Kong SAR, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.